Navigation Links
FDA Grants Charleston Laboratories, Inc. Request for Pre-IND Meeting on New Migraine Treatment
Date:4/16/2013

CHARLESTON, S.C., April 16, 2013 /PRNewswire/ -- Charleston Laboratories, Inc, an emerging specialty pharmaceutical company focused on the research and development of novel pain products that prevent or significantly reduce nausea and vomiting related to opioid analgesics and other pain associated disease states, announced today the U.S. Food and Drug Administration has granted its request for a Pre-IND meeting to discuss the proposed Investigational New Drug, CL-H1T, as a novel treatment for patients who suffer from migraine pain and migraine induced nausea or vomiting.   

"Charleston is very pleased with the response from the Neurology Products Division at FDA," said Mr. John Ameling , Vice President of Regulatory Affairs at Charleston.  "This meeting is a positive step towards the development of our novel migraine product, CL-H1T.  We look forward to discussing our proposed drug development program with FDA and initiating our clinical trials towards an approvable New Drug Application (NDA)."

"Our meeting with the agency in July is an important step in our development of CL-H1T," said Mr. Ryan Baker , Executive Vice President and Chief Operating Officer at Charleston Labs.  "After our meeting with FDA, we will be looking to enter into the best strategic partnership to successfully complete the clinical trials and support commercialization for CL-H1T to help the millions of patients suffering from migraine headaches and migraine induced nausea or vomiting."

"This milestone marks the second investigational drug in Charleston's pipeline to reach the clinic," Mr. Paul Bosse , President and Chief Executive Officer, commented.  "In addition to CL-108, which is in Phase 3 development for the treatment of acute moderate to severe pain, the development of
'/>"/>

SOURCE Charleston Laboratories, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. FDA Grants Chimerix Fast Track Designation for CMX001 for the Prevention of Clinically Significant Cytomegalovirus Infection
2. Pancreatic Cancer Action Network Opposes Sequestration Cuts To National Institutes Of Health & Cancer Research Grants
3. State Food and Drug Administration Grants Approval to Sihuan Pharmaceutical for Clinical Trial of Innovative Drug -- Pinoxacin Hydrochloride
4. Neuralstem Grants Licenses For Central Nervous System Therapy Surgical Devices To Cedars-Sinai Medical Center
5. FDA Grants Orphan Drug Status To Eisais Lenvatinib
6. FDA Grants 510(k) clearance for new Fluke Biomedical ESA615 Electrical Safety Analyzer
7. U.S. FDA Grants Priority Review to Bayers Radium Ra 223 Dichloride NDA for Castration-Resistant Prostate Cancer with Bone Metastases
8. Afraxis Grants Exclusive Global License to Genentech
9. FDA Grants Soligenix Fast Track Designation for OrbeShield(TM) for the Reduction of Mortality Associated with Gastrointestinal Acute Radiation Syndrome (GI ARS)
10. New Jersey Health Foundation Awards First Two Innovation Stage Funding Grants
11. Artemis Diagnostics awarded two grants from Technology Strategy Board to develop cancer imaging technology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/15/2014)... HAMILTON, N.J. , Sept. 15, 2014 /PRNewswire-iReach/ ... Bennett , University of South Carolina, submitted a ... FDA Commissioner, asking the FDA to add another ... antibiotic drug labels.  This request asks for a ... events:  "toxic psychoses, hallucinations, paranoia, suicidal thoughts or ...
(Date:9/15/2014)... and BRUSSELS , Sept. 15, 2014 ... UCB (Euronext Brussels:UCB) today announced results from several exploratory ... postmenopausal women with low bone mineral density (BMD). Romosozumab ... work by inhibiting the protein sclerostin, thereby increasing bone ... at the American Society for Bone and Mineral Research ...
(Date:9/15/2014)... DALLAS , Sept. 15, 2014 /PRNewswire-iReach/ -- MedicOne ... ambulance transport services, has been selected by Inc. ... companies in America. Photo - ... Inc. 500|5000 list identifies successful, privately-held companies with ... MedicOne Medical Response, one of only two ambulance ...
Breaking Medicine Technology:Quinolone Vigilance Foundation Supports Citizen Petition Requesting Another Black Box Warning for Levaquin, Cipro, Avelox 2Quinolone Vigilance Foundation Supports Citizen Petition Requesting Another Black Box Warning for Levaquin, Cipro, Avelox 3New Analyses Of Phase 2 Study Presented At ASBMR Show Romosozumab Treatment Resulted In Continued Increases In Bone Mineral Density 2New Analyses Of Phase 2 Study Presented At ASBMR Show Romosozumab Treatment Resulted In Continued Increases In Bone Mineral Density 3New Analyses Of Phase 2 Study Presented At ASBMR Show Romosozumab Treatment Resulted In Continued Increases In Bone Mineral Density 4New Analyses Of Phase 2 Study Presented At ASBMR Show Romosozumab Treatment Resulted In Continued Increases In Bone Mineral Density 5New Analyses Of Phase 2 Study Presented At ASBMR Show Romosozumab Treatment Resulted In Continued Increases In Bone Mineral Density 6New Analyses Of Phase 2 Study Presented At ASBMR Show Romosozumab Treatment Resulted In Continued Increases In Bone Mineral Density 7New Analyses Of Phase 2 Study Presented At ASBMR Show Romosozumab Treatment Resulted In Continued Increases In Bone Mineral Density 8New Analyses Of Phase 2 Study Presented At ASBMR Show Romosozumab Treatment Resulted In Continued Increases In Bone Mineral Density 9New Analyses Of Phase 2 Study Presented At ASBMR Show Romosozumab Treatment Resulted In Continued Increases In Bone Mineral Density 10New Analyses Of Phase 2 Study Presented At ASBMR Show Romosozumab Treatment Resulted In Continued Increases In Bone Mineral Density 11New Analyses Of Phase 2 Study Presented At ASBMR Show Romosozumab Treatment Resulted In Continued Increases In Bone Mineral Density 12New Analyses Of Phase 2 Study Presented At ASBMR Show Romosozumab Treatment Resulted In Continued Increases In Bone Mineral Density 13New Analyses Of Phase 2 Study Presented At ASBMR Show Romosozumab Treatment Resulted In Continued Increases In Bone Mineral Density 14New Analyses Of Phase 2 Study Presented At ASBMR Show Romosozumab Treatment Resulted In Continued Increases In Bone Mineral Density 15MedicOne Medical Response Named to 2014 Inc. 5000 Fastest Growing Companies List 2MedicOne Medical Response Named to 2014 Inc. 5000 Fastest Growing Companies List 3
(Date:9/16/2014)... 16, 2014 DiaperBuys, a national online ... Aging’ Month this September. Healthy Aging Month was started ... the nation on the positive aspects of growing older. ... conditions or side effects from medications that cause urinary ... Manager for DiaperBuys.com. “This can seem daunting to some ...
(Date:9/16/2014)... 2014 Banish headaches forever with the ... Cefaly device for chronic migraine relief and treatment. Cefaly ... United States. Until now, US patients would directly place ... Belgium and wait 2-3 weeks for their device to ... States and once prescription and payment is received, the ...
(Date:9/16/2014)... Reading, MA (PRWEB) September 16, 2014 ... announce its partnership with Fairfax Egg Bank. The collaboration ... and expand the donor egg offering at the Fertility ... operated since 2006 and offers the nation’s largest selection ... is advantageous for several reasons:, , ...
(Date:9/15/2014)... Missouri (PRWEB) September 16, 2014 The ... at Carey Danis & Lowe report that ... Corp., was found responsible for the injuries that a ... sling to treat stress urinary incontinence (SUI). , Carey ... defective medical device litigation and personal injury law. The ...
(Date:9/15/2014)... (PRWEB) September 16, 2014 Hastings and ... in Phoenix Arizona announces one flat attorney fee for ... that clients retain the largest portion possible of their ... expenses, lost wages and damaged personal property. In addition, ... to clients that simply states that no fees are ...
Breaking Medicine News(10 mins):Health News:DiaperBuys Honors ‘Healthy Aging’ Month throughout September 2Health News:DiaperBuys Honors ‘Healthy Aging’ Month throughout September 3Health News:Cefaly Migraine Treatment Device Now Readily Available For Widespread Purchase in United States 2Health News:FCNE Announces Partnership with Fairfax Egg Bank 2Health News:Carey Danis & Lowe Reports On $73 Million Boston Scientific Verdict 2Health News:Hastings And Hastings Announces One Flat Attorney Fee For Personal Injury Cases 2Health News:Hastings And Hastings Announces One Flat Attorney Fee For Personal Injury Cases 3
... highlight the dangers of infection from live birds, report ... peanut butter contaminated with salmonella has dominated the headlines ... is also prevalent in live poultry. , The Jan. ... and Prevention,s Morbidity and Mortality Weekly Report ...
... in a patient,s immune system that may lead to safer therapies ... as potential new ways to treat transplant rejection. , ... ... an abnormality in a patient,s immune system that may lead to ...
... Calif., Jan. 22 The following is a statement ... SEIU Trusteeship Hearing Officer Ray Marshall ruled against ... the founding of the Service Employees International Union in ... President the right to take over a local union. ...
... 22 Methodist Dallas Medical Center has been named ... in Community Service Award. The hospital is being honored ... The award was presented Jan. 22 at THA,s annual ... has screened more than 50,000 men since 2000, when ...
... in Financial Malpractice, Lays Out Recommendations to Protect Members ... Together for ChangeWASHINGTON, Jan. 22 In his Report ... on the trusteeship matter involving United Healthcare Workers - ... Marshall, the outside hearing officer, found that "Leaders of ...
... 22 At a meeting of its Board of Directors, ... on both the Common and Preferred Stock of the Company.A ... shares of Common Stock was declared payable on March 2, ... on February 13, 2009. In addition, a dividend of ...
Cached Medicine News:Health News:Salmonella Common In U.S. Poultry 2Health News:Salmonella Common In U.S. Poultry 3Health News:UCSF Finds Potential New Antibody Treatment for Autoimmune Diseases 2Health News:UCSF Finds Potential New Antibody Treatment for Autoimmune Diseases 3Health News:UHW Statement on Ray Marshall Trusteeship Recommendations 2Health News:Methodist Health System Prostate Cancer Screening Program Wins Statewide Community Service Award 2Health News:Methodist Health System Prostate Cancer Screening Program Wins Statewide Community Service Award 3Health News:SEIU IEB Unanimously Adopts Secretary Marshall's Report; UHW Given 5 Days to Comply with Union's Democratic Process and Decisions 2Health News:SEIU IEB Unanimously Adopts Secretary Marshall's Report; UHW Given 5 Days to Comply with Union's Democratic Process and Decisions 3
... The SmartDriver System consists of a pistol-grip ... Power, with a wide range of couplers ... of orthopedic surgical applications., ,The Battery ... speed compared to the original Battery SmartDriver. ...
... is an evolutionary product for the inside-out ... designed specifically for use with the Collagen ... becoming a new standard for use in ... a unique method to deliver sutures using ...
... Release System is a technological breakthrough in ... a minimally-invasive approach, provides significant patient benefits. ... of the wrist,creates an entry for the ... a standard video camera system, provides a ...
... a safe alternative to using positive displacement ... such as PCR(a), pipetting radioactive materials and ... excellent for tissue culture, gel loading, serological ... aerosol contaminants and liquids from reaching the ...
Medicine Products: